Xiangyu Medical Co.,Ltd Statistics
Total Valuation
SHA:688626 has a market cap or net worth of CNY 6.46 billion. The enterprise value is 6.17 billion.
| Market Cap | 6.46B |
| Enterprise Value | 6.17B |
Important Dates
The last earnings date was Friday, October 30, 2026.
| Earnings Date | Oct 30, 2026 |
| Ex-Dividend Date | Jun 17, 2026 |
Share Statistics
SHA:688626 has 156.07 million shares outstanding. The number of shares has increased by 1.95% in one year.
| Current Share Class | 156.07M |
| Shares Outstanding | 156.07M |
| Shares Change (YoY) | +1.95% |
| Shares Change (QoQ) | +8.42% |
| Owned by Insiders (%) | 5.94% |
| Owned by Institutions (%) | 6.06% |
| Float | 51.20M |
Valuation Ratios
The trailing PE ratio is 81.47 and the forward PE ratio is 65.03.
| PE Ratio | 81.47 |
| Forward PE | 65.03 |
| PS Ratio | 8.40 |
| PB Ratio | 2.98 |
| P/TBV Ratio | 3.33 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 37.09 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 78.00 |
| EV / Sales | 8.01 |
| EV / EBITDA | 58.00 |
| EV / EBIT | 159.07 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.10, with a Debt / Equity ratio of 0.16.
| Current Ratio | 2.10 |
| Quick Ratio | 1.24 |
| Debt / Equity | 0.16 |
| Debt / EBITDA | 3.20 |
| Debt / FCF | n/a |
| Interest Coverage | 188.78 |
Financial Efficiency
Return on equity (ROE) is 3.74% and return on invested capital (ROIC) is 2.08%.
| Return on Equity (ROE) | 3.74% |
| Return on Assets (ROA) | 0.77% |
| Return on Invested Capital (ROIC) | 2.08% |
| Return on Capital Employed (ROCE) | 1.56% |
| Weighted Average Cost of Capital (WACC) | 6.56% |
| Revenue Per Employee | 357,075 |
| Profits Per Employee | 36,681 |
| Employee Count | 2,155 |
| Asset Turnover | 0.24 |
| Inventory Turnover | 0.78 |
Taxes
In the past 12 months, SHA:688626 has paid 1.54 million in taxes.
| Income Tax | 1.54M |
| Effective Tax Rate | 1.92% |
Stock Price Statistics
The stock price has decreased by -19.77% in the last 52 weeks. The beta is 0.48, so SHA:688626's price volatility has been lower than the market average.
| Beta (5Y) | 0.48 |
| 52-Week Price Change | -19.77% |
| 50-Day Moving Average | 40.50 |
| 200-Day Moving Average | 51.87 |
| Relative Strength Index (RSI) | 51.59 |
| Average Volume (20 Days) | 3,409,507 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHA:688626 had revenue of CNY 769.50 million and earned 79.05 million in profits. Earnings per share was 0.51.
| Revenue | 769.50M |
| Gross Profit | 506.26M |
| Operating Income | 38.76M |
| Pretax Income | 80.29M |
| Net Income | 79.05M |
| EBITDA | 98.16M |
| EBIT | 38.76M |
| Earnings Per Share (EPS) | 0.51 |
Balance Sheet
The company has 646.34 million in cash and 340.13 million in debt, with a net cash position of 306.21 million or 1.96 per share.
| Cash & Cash Equivalents | 646.34M |
| Total Debt | 340.13M |
| Net Cash | 306.21M |
| Net Cash Per Share | 1.96 |
| Equity (Book Value) | 2.17B |
| Book Value Per Share | 13.56 |
| Working Capital | 629.09M |
Cash Flow
In the last 12 months, operating cash flow was 174.23 million and capital expenditures -183.04 million, giving a free cash flow of -8.82 million.
| Operating Cash Flow | 174.23M |
| Capital Expenditures | -183.04M |
| Depreciation & Amortization | 59.40M |
| Net Borrowing | 308.07M |
| Free Cash Flow | -8.82M |
| FCF Per Share | -0.06 |
Margins
Gross margin is 65.79%, with operating and profit margins of 5.04% and 10.27%.
| Gross Margin | 65.79% |
| Operating Margin | 5.04% |
| Pretax Margin | 10.43% |
| Profit Margin | 10.27% |
| EBITDA Margin | 12.76% |
| EBIT Margin | 5.04% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.18, which amounts to a dividend yield of 0.43%.
| Dividend Per Share | 0.18 |
| Dividend Yield | 0.43% |
| Dividend Growth (YoY) | -25.00% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 41.67% |
| FCF Payout Ratio | n/a |
| Buyback Yield | -1.95% |
| Shareholder Yield | -1.52% |
| Earnings Yield | 1.23% |
| FCF Yield | -0.14% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |